Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by houbahopon Apr 08, 2009 5:50pm

264 Views

Post# 15906121

RE: RE: Another institution in US is buying Thera

'"Shareholders might be holding stock in the next Bioval/Biochem Pharma"

There's nothing wrong in thinking thi stock could be in the $10+ in less then a year. After all, it was
there not so long ago.

I really like rounding bottoms!

When it enters into the parabolic phase, it is very rewarding when you're able to hold on your core position.

$2.25 is now officially out of the way. $4 should happen shortly.

Bullboard Posts

Sony’s Alpha 1 II: A new professional photography standard?